These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3711001)

  • 21. Blood cholesterol and serum magnesium in health and ischaemic heart disease.
    Raman BN; Vij SC; Maitrya BB
    J Indian Med Assoc; 1976 Mar; 66(6):124-6. PubMed ID: 965742
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum lipids and coagulation tests in coronary diseases].
    Chaudhuri S
    Pathol Biol (Paris); 1972 Nov; 20(21):881-6. PubMed ID: 4566243
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum alpha 1-antitrypsin activity in ischaemic heart disease.
    Vasantha VC; Somayajulu GL; Pai HS
    J Indian Med Assoc; 1985 Sep; 83(9):297-9. PubMed ID: 3878856
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum phospholipid pattern in patients with ischaemic heart disease.
    Bose SN; Deb S; Kundu SC; Batabyal SK
    Indian Heart J; 1984; 36(2):111-4. PubMed ID: 6724625
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum high density lipoprotein cholesterol (HDL-C) level and its regulating factors in healthy subjects and patients with coronary heart disease (author's transl)].
    Li ZX
    Zhonghua Yi Xue Za Zhi; 1982 Jan; 62(1):13-7. PubMed ID: 6805908
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum magnesium in ischaemic heart disease.
    Gupta RC; Bhagat JK; Sharma SK
    J Indian Med Assoc; 1980 Aug; 75(3):55-8. PubMed ID: 7217685
    [No Abstract]   [Full Text] [Related]  

  • 27. Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
    Kohler HP; Carter AM; Stickland MH; Grant PJ
    Thromb Haemost; 1998 Jan; 79(1):14-8. PubMed ID: 9459314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coronary sclerosis and myocardial infarct in the West German Federal Republic 1945-1965].
    Schettler G; Hild R
    Pathol Microbiol (Basel); 1967; 30(5):766-76. PubMed ID: 5585920
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in the share of phosphatidylcholine in total phospholipid concentration in patients with ischaemic heart disease and after myocardial infarction (author's transl)].
    Votruba M; Schmidtová H; Rouchal J; Vacková V
    Cas Lek Cesk; 1981 Jul; 120(27):823-5. PubMed ID: 7261003
    [No Abstract]   [Full Text] [Related]  

  • 30. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipoproteins and coronary cardiopathy].
    Angelino PF; Abrate M; Pizzuti A; Bernardi FR; Bulgarelli GC; Aillon C; Passarino G; Carta Q; Della Beffa V
    Minerva Cardioangiol; 1981 Apr; 29(4):163-7. PubMed ID: 7242947
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum triglyceride and lipoprotein cholesterol in male survivor of ischaemic heart disease in eastern Uttar Pradesh (north India).
    Kabi BC; Somani PN; Koteswara Rao GR
    Indian Heart J; 1985; 37(3):176-8. PubMed ID: 4065916
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 34. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid abnormalities in coronary heart disease: a population-based case-control study.
    Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP
    Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Induced platelet aggregation in patients with coronary heart disease as well as trained and untrained control persons].
    Lehmann M; Hasler K; Hasenfuss G; Holubarsch C; Staiger A; Kasper W; Keul J
    Z Kardiol; 1985 Oct; 74(10):611-7. PubMed ID: 4072333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial hyperlipidemia in coronary atherosclerotic heart disease.
    Das SK; Shukla RN; Chandra M; Nityanand S; Agarwal SS
    J Assoc Physicians India; 1983 Jan; 31(1):15-9. PubMed ID: 6619068
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum cholesterol in relation to blood groups in ischaemic heart disease.
    Chakraborti S; Banerjee PK
    J Indian Med Assoc; 1974 Sep; 63(5):150-2. PubMed ID: 4448914
    [No Abstract]   [Full Text] [Related]  

  • 39. Secondary prevention of coronary heart disease.
    Lancet; 1989 Apr; 1(8640):718-9. PubMed ID: 2564521
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cholesterol and the severity of coronary disease. Its value in the prognosis following myocardial infarction].
    Coll S; Castañer A; Betriu A; Magriña J; Soler J; Azqueta M; Navarro-López F
    Rev Esp Cardiol; 1983; 36(1):21-5. PubMed ID: 6878805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.